You are here:
28 January 2015
What Gavi will do now
Gavi CEO Seth Berkley explains what Gavi will be able to do with $7.5 billion.
27 January 2015
Saving Lives - A Live Report
Gavi Deputy CEO Anuradha Gupta talks about the real-life impact of immunisation with health workers Sawadago Abdoulaye from Burkina Faso and Dr Faisa Ibrahim from Somalia.
22 January 2015
Gavi celebrates 15 years of saving lives
Highlights from a decade and a half of helping countries protect 500 million people with vaccines.
02 September 2014
South Sudan overcomes great obstacles to protect children
Despite conflict, the South Sudanese government brings in five-in-one pentavalent vaccine with Gavi support.
30 July 2014
73 countries, five diseases, one amazing vaccine
How the 5-in-1 pentavalent vaccine is now protecting children in all of the world's poorest countries
27 November 2013
GAVI supported rotavirus vaccines introduced in Zambia
Following a successful pilot program delivering rotavirus vaccines as part of an integrated approach to diarrhoea prevention and control, in November 2013, Zambia rolled out GAVI-supported rotavirus vaccines nationwide. Rotavirus, the most common cause of severe and fatal diarrhoea in young children worldwide, takes the lives of over 3,600 Zambian children under five each year and accounts for approximately 40 percent of all under-five diarrhoeal deaths and hospitalisations. Zambia is the 18th GAVI-eligible country to introduce rotavirus vaccines in its national immunisation program. (credit VITAC-PATH)
10 December 2014
CEO Board Report December 2014
Topics covered include: Key events and updates ; Vaccine introductions ; Broader landscape ; Resource mobilisation ; Coverage and equity ; Risk management ; Going forward.
28 October 2014
Pentavalent: 1 vaccine, 5 diseases, 73 countries
The 5-in-1 pentavalent vaccine is now available in all Gavi-supported countries at a record low price, but only 50% of the children are being reached. Learn more about the pentavalent success story – and the challenges that remain.
27 October 2014
Immunisation progress in Asia-Pacific
Presentation on immunisation in Asia-Pacific, including support for pentavalent, pneumococcal, measles, rubella, HPV, Japanese encephalitis, hepatitis B and inactivated polio vaccines, the growing number of manufacturers of Gavi-funded vaccines based in the region, and the increasing co-financing contributions by countries. Despite this progress, challenges remain: almost half of the world’s under-immunised children are in Gavi-supported countries in Asia-Pacific.
Immunisation: No other health intervention touches so many lives
Today, 30 vaccine doses are administered in the world every second.With full funding, developing countries will immunise two children every second with Gavi-supported vaccines (2016-2020).
Download high resolution PDF version
28 November 2014
Increasing support for immunisation in Francophone countries
Current information and projections for increased support for Francophone countries by Gavi during the period 2016 - 2020.
Download high resolution PDF version
12 November 2014
Pneumococcal disease: the biggest vaccine-preventable cause of death in children under five
Pneumonia kills as many as 1 million children under five and pneumococcal disease is the leading cause of pneumonia. Countries introducing pneumococcal vaccines with Gavi support could prevent 500,000 early deaths by 2015.
Gavi broadcast quality video:
The latest Gavi B-roll is available for interested broadcasters to review at: www.gavivideo.org
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here